Further analysis showed a similar trend in the levels of CD33+CD11b+ cells; CRC patients showed significantly higher levels of CD33+CD11b+ subsets compared with HDs (CRC: 81.9 ± 2.1% vs. HD: 74.6 ± 2.6%; Figure 1B). The gene discussed is ITGAM; the disease is colorectal carcinoma.